05.22.18
Heidelberg Engineering’s Spectralis OCT2 Module Headed to the International Space Station
Source: Heidelberg Engineering
Heidelberg Engineering announced that the Spectralis imaging platform with the company’s next-generation OCT2 Module is headed for the International Space Station (ISS).
NASA launched the Spectralis with OCT2 Module to the ISS aboard the Antares 230 Cygnus CRS OA-9, also known as Orbital Sciences CRS Flight 9E on May 21, 2018, from Wallops Island, Virginia. The device will be installed on the ISS in late 2018.
“The Spectralis with OCT2 Module uses patented TruTrack Active Eye Tracking,” Ali Tafreshi, Director of Clinical Research for Heidelberg Engineering, said in a company news release. “The technology uses a second laser beam to actively track the eye during OCT scanning to effectively ‘freeze’ the retina and avoid motion artifacts. With this technology, a p
Read Article
Featured Stories
05.22.18
Nidek Launches the LSFG-RetFlow Laser Speckle Flowgraphy
Source: Nidek
05.18.18
Burnout, Depression Can Affect Ophthalmology Residents, Study Finds
Source: Brown University
05.15.18
Aerie Submits New Drug Application to FDA for Roclatan
Source: Aerie Pharmaceuticals
Latest News
05.22.18
Tear Film Innovations Completes $8.5 Million Series B FundingSource: Tear Film Innovations
05.22.18
Researchers Identify Genetic Variants that May Predict Glaucoma RiskSource: King's College London
05.22.18
New System Allows Trainee Doctors to Use Virtual Reality to Learn Eye Examination DiagnosesSource: Birmingham City University
05.21.18
Ophthalmic Diagnostic Equipment Market to Generate $3.3 Billion in 2018Source: Market Scope
05.21.18
Iconic Therapeutics Initiates Second Phase 2 Study of ICON-1 in Patients With Wet AMDSource: Iconic Therapeutics
05.21.18
Academy 2018 San Antonio Registration and Housing Now OpenSource: The American Academy of Optometry
05.18.18
Vitrisa Therapeutics Acquires Rights to MAKO Clinical Trial Data in Wet AMDSource: Vitrisa Therapeutics
05.17.18
Valeant’s Ex-CEO Jumped into Philidor Deal Even After Being Warned of Potential Collusion, Jurors ToldSource: FiercePharma